Vektor Medical to Present Positive Results from vMap Clinical Validation Study Showing 97.3% Mapping Accuracy for Atrial and Ventricular Arrhythmias
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Hannah Boxerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Nancy Lelicoff Joins as Executive Vice President of Regulatory, Quality Assurance and Clinical Affairs Global molecular diagnostics innovator,Sense Biodetection (Sense), today announced the appointment
Press release content from Business Wire. The AP news staff was not involved in its creation.
Marty Rochesterâs March 24 opinion piece, âOy vey: The excesses of identity politics,â cries out for rebuttal on a number of fronts. Since Iâm having trouble deciding whether I am, in Rochesterâs words, a âgarden-variety liberalâ or a âleft-wing extremist,â Iâll let other more astute readers…
Azura Ophthalmics Announces Primary Endpoints Met in Topline Results from Phase 2 Trial of the Company’s Investigational Treatment for Contact Lens Discomfort Significant improvement in multiple measures of Meibomian gland secretion and associated improvements in contact lens wear time TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye diseases, today announced topline results from a phase 2 clinical trial evaluating the company’s investigational th...